Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spring Kong

Showing results (91-100 of 156) with videos related to

Pageof 16
Sort By:
Frontiers in Immunology|July 6, 2026
Single dose of 5 Gy can damage erythrocytes and consequently induces lymphocyte depletion in spleen and circulating bloodPeimeng You, Xiaohang Qin, Yinghui Li, et al.
Practical Radiation Oncology|June 17, 2018
Functional liver image guided hepatic therapy (FLIGHT) with hepatobiliary iminodiacetic acid (HIDA) scansDavid E Long, Mark Tann, Ke Colin Huang, et al.
Radiation Oncology (London, England)|January 29, 2014
Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapyShuanghu Tiger Yuan, Richard K J Brown, Lujun Zhao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2010
Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation breakLuying Xu, Jianji Pan, Junxin Wu, et al.
Cancer Biomarkers : Section a of Disease Markers|January 31, 2022
Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancerLi Yang, Zhiyuan Xu, Lingyu Ma, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2018
Chest Wall Toxicity After Stereotactic Body Radiation Therapy: A Pooled Analysis of 57 StudiesJie-Tao Ma, Yang Liu, Li Sun, et al.
Translational Lung Cancer Research|December 9, 2017
Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparationFeng-Ming Spring Kong, Lujun Zhao, Luhua Wang, et al.
Annals of Palliative Medicine|February 7, 2021
Radiation-induced lung damage in patients treated with stereotactic body radiotherapy after EGFR-TKIs: is there any difference from stereotactic body radiotherapy alone?Xingni Tang, Yichao Shen, Yinnan Meng, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 13, 2018
Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancerJianxin Xue, Chengbo Han, Andrew Jackson, et al.
Practical Radiation Oncology|November 22, 2014
Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning studyYunfeng Cui, Wenzhou Chen, Feng-Ming Spring Kong, et al.
Pageof 16

Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Frontiers in Immunology|July 6, 2026
Single dose of 5 Gy can damage erythrocytes and consequently induces lymphocyte depletion in spleen and circulating bloodPeimeng You, Xiaohang Qin, Yinghui Li, et al.
Practical Radiation Oncology|June 17, 2018
Functional liver image guided hepatic therapy (FLIGHT) with hepatobiliary iminodiacetic acid (HIDA) scansDavid E Long, Mark Tann, Ke Colin Huang, et al.
Radiation Oncology (London, England)|January 29, 2014
Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapyShuanghu Tiger Yuan, Richard K J Brown, Lujun Zhao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2010
Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation breakLuying Xu, Jianji Pan, Junxin Wu, et al.
Cancer Biomarkers : Section a of Disease Markers|January 31, 2022
Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancerLi Yang, Zhiyuan Xu, Lingyu Ma, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2018
Chest Wall Toxicity After Stereotactic Body Radiation Therapy: A Pooled Analysis of 57 StudiesJie-Tao Ma, Yang Liu, Li Sun, et al.
Translational Lung Cancer Research|December 9, 2017
Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparationFeng-Ming Spring Kong, Lujun Zhao, Luhua Wang, et al.
Annals of Palliative Medicine|February 7, 2021
Radiation-induced lung damage in patients treated with stereotactic body radiotherapy after EGFR-TKIs: is there any difference from stereotactic body radiotherapy alone?Xingni Tang, Yichao Shen, Yinnan Meng, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 13, 2018
Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancerJianxin Xue, Chengbo Han, Andrew Jackson, et al.
Practical Radiation Oncology|November 22, 2014
Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning studyYunfeng Cui, Wenzhou Chen, Feng-Ming Spring Kong, et al.
Pageof 16